Patient Perceptions and Willingness to Enroll in Clinical Trials

The objective of our study is to determine which factors affect willingness to participate in gynecologic oncology clinical trials. Women with a diagnosis of gynecologic malignancy will be approached to complete a survey assessing willingness to participate in clinical trials. The validated Attitudes and Randomized Trials Questionnaire (ARTQ) will be used to assess willingness to participate.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer, Clinical Trials Neoplasms

Age range

18 year–90 year

Sex eligibility

Female

Study type

Observational

Primary location

University of Virginia

Charlottesville, Virginia, 22902, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of gynecologic malignancy
English or Spanish literate

Exclusion criteria

Prior enrollment in a clinical trial
Currently pregnant
Currently incarcerated

Treatment and study plan

Survey

Other

Attitudes and Randomized Trial Questionnaire (ARTQ), Hospital Anxiety and Depression Scale, Perception Survey

Primary outcomes

Willingness to Participate in Clinical Trials

Time frame: 6 months

Bivariate outcome derived from ARTQ survey

Sponsors and collaborators

Lead sponsor

University of Virginia

Other

Registry information

Important dates

Study start: 2017
Primary completion: 2018
Study completion: 2018
First posted: Jul 27, 2017
Registry last updated: Oct 10, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed